JABFM
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF) Freely available
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutknecht, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutknecht, D. R.

The Journal of the American Board of Family Practice, Vol 14, Issue 3 197-200, Copyright © 2001 by American Board of Family Practice

ARTICLES

Evidence-based advertising? A survey of four major journals

D. R. Gutknecht
Department of General Internal Medicine, Geisinger Medical Center, Danville, PA 17822, USA.

BACKGROUND: Pharmaceutical advertisements are an important means of bringing drug information to physicians. Most advertisements are intended only to raise awareness, though there are those that do seek to persuade through presentation of research findings. Researchers have questioned the quality of the research reported in advertisements and wonder whether these advertisements would lead to improper prescribing. METHODS: A consecutive 6-month sample of advertisements in 4 general medical journals, 3 from the United States and 1 from Canada, were reviewed to determine how research results are presented in pharmaceutical advertisements. RESULTS: During this time there were 187 distinctive advertisements, with 43 data presentations in the 33 advertisements that contained quantitative research results. These results were examined using a critical appraisal worksheet. References to randomization and blinding were found in less than one half of the 43 data presentations. P values were frequently provided, but confidence intervals and references to power and number needed to treat were not provided in any of the advertisements. CONCLUSIONS: Descriptions of research in pharmaceutical advertisements were brief and incomplete, and they inconsistently provided the basic design and statistical information needed to judge the results reported. More detail could make these advertisements more meaningful to critical readers.


This article has been cited by other articles:


Home page
 JBJSHome page
J. M. Purvis, A. H. Alexander, T. A. Einhorn, and L. Y. Griffin
Symposium Evaluating the Flood of Orthopaedic Media and Marketing Information
J. Bone Joint Surg. Am., June 1, 2005; 87(6): 1392 - 1398.
[Full Text] [PDF]

Home page
 CMAJHome page
R. J. Cooper and D. L. Schriger
The availability of references and the sponsorship of original research cited in pharmaceutical advertisements
Can. Med. Assoc. J., February 15, 2005; 172(4): 487 - 491.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Board of Family Medicine.